标题
Immunotherapy for Prostate Cancer: Where We Are Headed
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 12, Pages 2627
出版商
MDPI AG
发表日期
2017-12-06
DOI
10.3390/ijms18122627
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer
- (2017) Michael A. Bookman et al. GYNECOLOGIC ONCOLOGY
- Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
- (2017) Tomasz M. Beer et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients
- (2017) Luc Cabel et al. Journal for ImmunoTherapy of Cancer
- Pembrolizumab for patients with advanced prostate adenocarcinoma: Preliminary results from the KEYNOTE-028 study
- (2016) A. Hansen et al. ANNALS OF ONCOLOGY
- Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy
- (2016) Giuseppe Schepisi et al. BIODRUGS
- Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell Clusters
- (2016) Anders Carlsson et al. CLINICAL CANCER RESEARCH
- Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma
- (2016) Alberto Farolfi et al. Expert Opinion on Drug Metabolism & Toxicology
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone
- (2016) Cristian Lolli et al. Frontiers in Pharmacology
- Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer
- (2016) Vincenza Conteduca et al. PLoS One
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
- (2015) Elena Castro et al. EUROPEAN UROLOGY
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
- (2015) Huong D. Meeks et al. JNCI-Journal of the National Cancer Institute
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
- (2015) Huong D. Meeks et al. JNCI-Journal of the National Cancer Institute
- Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm
- (2015) James L. Gulley et al. OncoImmunology
- DNA repair mechanisms in cancer development and therapy
- (2015) Alessandro Torgovnick et al. Frontiers in Genetics
- Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
- (2014) D. Lorente et al. ANNALS OF ONCOLOGY
- Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer
- (2014) Guru Sonpavde et al. Clinical Genitourinary Cancer
- Neuroendocrine differentiation in prostate cancer: Current and emerging therapy strategies
- (2014) Vincenza Conteduca et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone
- (2014) Salvatore Luca Burgio et al. ENDOCRINE-RELATED CANCER
- Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel
- (2014) Ahmet Taner Sümbül et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Tumor infiltrating B-cells are increased in prostate cancer tissue
- (2014) Jason R Woo et al. Journal of Translational Medicine
- Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
- (2014) Eugene D Kwon et al. LANCET ONCOLOGY
- Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide
- (2014) Vincenza Conteduca et al. PROSTATE
- The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical Prostatectomy
- (2014) M. Lanciotti et al. Biomed Research International
- Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
- (2013) S. F. Slovin et al. ANNALS OF ONCOLOGY
- Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer
- (2013) A Rojas-Martínez et al. CANCER GENE THERAPY
- An IKK -E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence
- (2013) M. Ammirante et al. GENES & DEVELOPMENT
- GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
- (2013) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy
- (2013) C G Drake et al. ONCOGENE
- Lower Baseline Prostate-specific Antigen Is Associated With a Greater Overall Survival Benefit From Sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) Trial
- (2013) Paul F. Schellhammer et al. UROLOGY
- Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer
- (2012) Anna Flammiger et al. APMIS
- BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
- (2012) Jessica N McAlpine et al. MODERN PATHOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low serum neutrophil count predicts a positive prostate biopsy
- (2012) K Fujita et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features
- (2011) V. Tzelepi et al. CLINICAL CANCER RESEARCH
- Cytotoxic immunotherapy strategies for cancer: Mechanisms and clinical development
- (2011) Laura K. Aguilar et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer
- (2010) Norio Nonomura et al. BJU INTERNATIONAL
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
- (2010) Massimo Ammirante et al. NATURE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters
- (2009) Kathleen Ebelt et al. EUROPEAN JOURNAL OF CANCER
- Promising novel immunotherapies and combinations for prostate cancer
- (2009) Philip M Arlen et al. Future Oncology
- Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
- (2009) Jedd D Wolchok et al. LANCET ONCOLOGY
- Human prostate-infiltrating CD8+T lymphocytes are oligoclonal and PD-1+
- (2009) Karen S. Sfanos et al. PROSTATE
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss
- (2008) Blaise Clarke et al. MODERN PATHOLOGY
- Sipuleucel-T: A Vaccine for Metastatic, Asymptomatic, Androgen-Independent Prostate Cancer
- (2007) Punam H Patel et al. ANNALS OF PHARMACOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation